AdvocacyCommunity Event
Public Meeting on the Reauthorization of BsUFA
Monday, October 26, 2026 · 9:00 AM EDT
10903 New Hampshire Avenue, Silver Spring, MD 20993
🤝civic engagement
About this event
The FDA is holding a hybrid public meeting on the reauthorization of the Biosimilar User Fee Act (BsUFA).
Event details
This listing is gathered from a public source and may have changed. Confirm the date, time, location, and other event details with the original source before attending.
Some advocacy events held at private residences may require RSVP or registration. Check the source for details before attending.